Phase 1 Trial to Determine Safety and Feasibility in Treating Biochemical Recurrence Post-Prostatectomy with PSMA PET Guided External Beam Radiotherapy Followed by Consolidative Radioligand Therapy
Latest Information Update: 31 Dec 2024
At a glance
- Drugs Fluorine 18 flotufolastat (Primary) ; Lutetium 177 rhPSMA (Primary)
- Indications Adenocarcinoma; Prostate cancer
- Focus Adverse reactions
Most Recent Events
- 04 Dec 2023 Status changed from not yet recruiting to recruiting.
- 02 Nov 2023 New trial record